Skip to main content
Kelsey Ichikawa on Muck Rack

Kelsey Ichikawa

As seen in: Memory Studies, SAGE Publishing, Vox, Tampa Bay Times, Genetic Literacy Project, Nautilus, RealClear Science
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kelsey

Contact Kelsey, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The story about Ambien and sex differences in medication isn’t what you think

|
By Kelsey Ichikawa, Marina DiMarco
| Vox Verified
Getty Images This story is part of a group of stories called Finding the best ways to do good. Zolpidem tartrate is infamous. It walks the street with many names: “A-minus,” “zombie pills,” “no-go pills.” It has been blamed for a range of strange and disastrous incidents in the news over the years, including Roseanne Barr’s racist tweeting in 2018 and Tiger Woods’s terrible car accident in 2021.
Open in Who Shared View Duplicates (7) Issue with article?

Making a ‘sex-difference fact’: Ambien dosing at the interface of policy, regulation, women’s health, and biology

|
By Helen Zhao, Marina DiMarco, Kelsey Ichikawa, Marion Boulicault
| SAGE Publishing
The making of a hallmark sex-difference fact Zolpidem bears comparison to the drug BiDil, a combination of heart medications approved in 2005 for use in African Americans. BiDil, the first race-specific drug approved by the FDA, was touted as a sign of progress in pharmacogenomics and a stepping stone toward precision medicine.
Open in Who Shared Issue with article?

Making a ‘sex-difference fact’: Ambien dosing at the interface of policy, regulation, women’s health, and biology

|
By Helen Zhao, Marina DiMarco, Kelsey Ichikawa, Marion Boulicault
| SAGE Publishing
Helen Zhao is a philosopher of science who works on values in science and medicine. Marina DiMarco is a philosopher of science who works on feminism, biology, and medicine. Kelsey Ichikawa is an STS researcher and the lab manager of the Harvard GenderSci Lab. Marion Boulicault is a philosopher of science who takes a feminist approach to questions in the ethics of technology, philosophy of science, and bioethics, with a focus on measurement and quantification practices.
Open in Who Shared Issue with article?
See all 12 licensed articles (13 Total)